- Advertisement -
The landscape of medical research is witnessing significant growth in cannabinoid clinical trials, with over 50 companies actively engaged in developing novel therapies. A recent report, ‘Cannabinoid Pipeline Insight 2025,’ from DelveInsight Business Research LLP highlights a robust pipeline…
